General Surgical Innovations aims to expand minimally invasive surgery (MIS)
This article was originally published in Clinica
General Surgical Innovations (GSI) aims to raise $27 million from the sale of 2.5 million shares at an assumed price of $12. The amount could rise to $31 million if the underwriters' overallotment is exercised in full. The developer of balloon dissection systems for minimally invasive surgery plans to use $9 million of the proceeds of its IPO to expand sales of its Spacemaker systems. Part of the IPO proceeds will go towards expanding GSI's facility in Palo Alto, California.
You may also be interested in...
Companion diagnostics are needed increasingly by pharma companies to justify the safety and effectiveness of their products. With specific first-time EU regulation of these products within sight – and urgently needed – is there a risk of delays to these products being able to demonstrate compliance?
Draft policy moots crowdfunding for high-cost rare diseases alongside financial support for those "amenable to one-time treatment" but falls way short of some patient groups' expectations.